BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 17662905)

  • 1. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rational approach to the treatment of vitiligo and other hypomelanoses.
    Hercogová J; Buggiani G; Prignano F; Lotti T
    Dermatol Clin; 2007 Jul; 25(3):383-92, ix. PubMed ID: 17662904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma.
    Vanscheidt W; Hunziker T
    Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depigmentation therapies for normal skin in vitiligo universalis.
    AlGhamdi KM; Kumar A
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.
    Goldinger SM; Dummer R; Schmid P; Burg G; Seifert B; Läuchli S
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo road map.
    Lee BW; Schwartz RA; Hercogová J; Valle Y; Lotti TM
    Dermatol Ther; 2012; 25 Suppl 1():S44-56. PubMed ID: 23237038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments of vitiligo: what's new at the horizon.
    Lotti TM; Hercogová J; Schwartz RA; Tsampau D; Korobko I; Pietrzak A; Mitrevska NT; Valle Y; Buggiani G
    Dermatol Ther; 2012; 25 Suppl 1():S32-40. PubMed ID: 23237036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo therapy: where are we now?
    Arroyo MP; Tift L
    J Drugs Dermatol; 2003 Aug; 2(4):404-8. PubMed ID: 12884463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study.
    Klahan S; Asawanonda P
    Clin Exp Dermatol; 2009 Dec; 34(8):e1029-30. PubMed ID: 20055831
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitiligo: to treat or not to treat.
    Lim HW; Hexsel CL
    Arch Dermatol; 2007 May; 143(5):643-6. PubMed ID: 17515516
    [No Abstract]   [Full Text] [Related]  

  • 14. Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review.
    Nicolaidou E; Antoniou C; Stratigos A; Katsambas AD
    J Am Acad Dermatol; 2009 Mar; 60(3):470-7. PubMed ID: 19157641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitiligo: an update on current pharmacotherapy and future directions.
    Colucci R; Lotti T; Moretti S
    Expert Opin Pharmacother; 2012 Sep; 13(13):1885-99. PubMed ID: 22835073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's New in Pigmentary Disorders.
    Zubair R; Lyons AB; Vellaichamy G; Peacock A; Hamzavi I
    Dermatol Clin; 2019 Apr; 37(2):175-181. PubMed ID: 30850040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo nonsurgical treatment: a review of latest treatment researches.
    Zhang Y; Mooneyan-Ramchurn JS; Zuo N; Feng Y; Xiao S
    Dermatol Ther; 2014; 27(5):298-303. PubMed ID: 25041437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture.
    Gawkrodger DJ
    Br J Dermatol; 2009 Oct; 161(4):721-2. PubMed ID: 19780755
    [No Abstract]   [Full Text] [Related]  

  • 19. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
    El-Zawahry BM; Zaki NS; Bassiouny DA; Sobhi RM; Zaghloul A; Khorshied MM; Gouda HM
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanin pigmentary disorders: treatment update.
    Ortonne JP; Passeron T
    Dermatol Clin; 2005 Apr; 23(2):209-26. PubMed ID: 15837152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.